Bruce Culleton - Dec 3, 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
Chief Executive Officer, Director
Signature
/s/ Todd Girolamo, attorney in fact
Stock symbol
PROK
Transactions as of
Dec 3, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 04:04 PM
Previous filing
Aug 3, 2023
Next filing
Sep 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +2M $0.00 2M Dec 3, 2023 Class A Ordinary Shares 2M $1.69 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price is equal to the greater of (i) the thirty day average stock price of the Company's Class A Ordinary Shares on the Nasdaq Stock Market ("Nasdaq") as of the date of grant (the "Grant Date") and (ii) the closing price of the Company's Class A Ordinary Shares on Nasdaq as of the Grant Date.
F2 The option vests 25% on the first anniversary of November 15, 2023 and the remaining 75% vests in substantially equal quarterly installments over the following 36 months on each quarterly anniversary of November 15, 2023, subject to continued employment through each such vesting date.